カテゴリ： Market Monitor Global, 世界, 医療/バイオ

腫瘍治療薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、ホルモン療法、その他

■ 英語タイトル：Oncology Therapeutic Drug Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5829）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5829
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆医療
■ ページ数：120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[腫瘍治療薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、ホルモン療法、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の腫瘍治療薬市場規模と予測を収録しています。・世界の腫瘍治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「化学療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

腫瘍治療薬のグローバル主要企業は、AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、腫瘍治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の腫瘍治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：タイプ別市場シェア、2022年
・化学療法、標的療法、免疫療法、ホルモン療法、その他

世界の腫瘍治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：用途別市場シェア、2022年
・乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他

世界の腫瘍治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における腫瘍治療薬のグローバル売上、2018年-2023年
・主要企業における腫瘍治療薬のグローバル売上シェア、2022年
・主要企業における腫瘍治療薬のグローバル販売量、2018年-2023年
・主要企業における腫瘍治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industries

*************************************************************

・調査・分析レポートの概要
腫瘍治療薬市場の定義
市場セグメント
世界の腫瘍治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍治療薬市場規模
世界の腫瘍治療薬市場規模：2022年 VS 2029年
世界の腫瘍治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：化学療法、標的療法、免疫療法、ホルモン療法、その他
腫瘍治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他
腫瘍治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍治療薬市場規模 2022年と2029年
地域別腫瘍治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industries
...

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report aims to provide a comprehensive presentation of the global market for Oncology Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Therapeutic Drug. This report contains market size and forecasts of Oncology Therapeutic Drug in global, including the following market information:
Global Oncology Therapeutic Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oncology Therapeutic Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oncology Therapeutic Drug companies in 2022 (%)
The global Oncology Therapeutic Drug market was valued at US$ 203160 million in 2022 and is projected to reach US$ 340480 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry’s leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Therapeutic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Therapeutic Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Global Oncology Therapeutic Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory and Lung Cancer
Others
Global Oncology Therapeutic Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Therapeutic Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oncology Therapeutic Drug revenues share in global market, 2022 (%)
Key companies Oncology Therapeutic Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oncology Therapeutic Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Astellas Pharma
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Celgene
Eisai
Eli Lilly and Company
Gilead Sciences
Ipsen
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
F. Hoffmann-La Roche
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Therapeutic Drug, market overview.
Chapter 2: Global Oncology Therapeutic Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology Therapeutic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology Therapeutic Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Oncology Therapeutic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Therapeutic Drug Overall Market Size
2.1 Global Oncology Therapeutic Drug Market Size: 2022 VS 2029
2.2 Global Oncology Therapeutic Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oncology Therapeutic Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Oncology Therapeutic Drug Players in Global Market
3.2 Top Global Oncology Therapeutic Drug Companies Ranked by Revenue
3.3 Global Oncology Therapeutic Drug Revenue by Companies
3.4 Global Oncology Therapeutic Drug Sales by Companies
3.5 Global Oncology Therapeutic Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oncology Therapeutic Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oncology Therapeutic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Therapeutic Drug Players in Global Market
3.8.1 List of Global Tier 1 Oncology Therapeutic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology Therapeutic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncology Therapeutic Drug Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type – Global Oncology Therapeutic Drug Revenue & Forecasts
4.2.1 By Type – Global Oncology Therapeutic Drug Revenue, 2018-2023
4.2.2 By Type – Global Oncology Therapeutic Drug Revenue, 2024-2029
4.2.3 By Type – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Oncology Therapeutic Drug Sales & Forecasts
4.3.1 By Type – Global Oncology Therapeutic Drug Sales, 2018-2023
4.3.2 By Type – Global Oncology Therapeutic Drug Sales, 2024-2029
4.3.3 By Type – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
4.4 By Type – Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncology Therapeutic Drug Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Gastrointestinal Cancer
5.1.4 Prostate Cancer
5.1.5 Respiratory and Lung Cancer
5.1.6 Others
5.2 By Application – Global Oncology Therapeutic Drug Revenue & Forecasts
5.2.1 By Application – Global Oncology Therapeutic Drug Revenue, 2018-2023
5.2.2 By Application – Global Oncology Therapeutic Drug Revenue, 2024-2029
5.2.3 By Application – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Oncology Therapeutic Drug Sales & Forecasts
5.3.1 By Application – Global Oncology Therapeutic Drug Sales, 2018-2023
5.3.2 By Application – Global Oncology Therapeutic Drug Sales, 2024-2029
5.3.3 By Application – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
5.4 By Application – Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oncology Therapeutic Drug Market Size, 2022 & 2029
6.2 By Region – Global Oncology Therapeutic Drug Revenue & Forecasts
6.2.1 By Region – Global Oncology Therapeutic Drug Revenue, 2018-2023
6.2.2 By Region – Global Oncology Therapeutic Drug Revenue, 2024-2029
6.2.3 By Region – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Oncology Therapeutic Drug Sales & Forecasts
6.3.1 By Region – Global Oncology Therapeutic Drug Sales, 2018-2023
6.3.2 By Region – Global Oncology Therapeutic Drug Sales, 2024-2029
6.3.3 By Region – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oncology Therapeutic Drug Revenue, 2018-2029
6.4.2 By Country – North America Oncology Therapeutic Drug Sales, 2018-2029
6.4.3 US Oncology Therapeutic Drug Market Size, 2018-2029
6.4.4 Canada Oncology Therapeutic Drug Market Size, 2018-2029
6.4.5 Mexico Oncology Therapeutic Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oncology Therapeutic Drug Revenue, 2018-2029
6.5.2 By Country – Europe Oncology Therapeutic Drug Sales, 2018-2029
6.5.3 Germany Oncology Therapeutic Drug Market Size, 2018-2029
6.5.4 France Oncology Therapeutic Drug Market Size, 2018-2029
6.5.5 U.K. Oncology Therapeutic Drug Market Size, 2018-2029
6.5.6 Italy Oncology Therapeutic Drug Market Size, 2018-2029
6.5.7 Russia Oncology Therapeutic Drug Market Size, 2018-2029
6.5.8 Nordic Countries Oncology Therapeutic Drug Market Size, 2018-2029
6.5.9 Benelux Oncology Therapeutic Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oncology Therapeutic Drug Revenue, 2018-2029
6.6.2 By Region – Asia Oncology Therapeutic Drug Sales, 2018-2029
6.6.3 China Oncology Therapeutic Drug Market Size, 2018-2029
6.6.4 Japan Oncology Therapeutic Drug Market Size, 2018-2029
6.6.5 South Korea Oncology Therapeutic Drug Market Size, 2018-2029
6.6.6 Southeast Asia Oncology Therapeutic Drug Market Size, 2018-2029
6.6.7 India Oncology Therapeutic Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oncology Therapeutic Drug Revenue, 2018-2029
6.7.2 By Country – South America Oncology Therapeutic Drug Sales, 2018-2029
6.7.3 Brazil Oncology Therapeutic Drug Market Size, 2018-2029
6.7.4 Argentina Oncology Therapeutic Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oncology Therapeutic Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oncology Therapeutic Drug Sales, 2018-2029
6.8.3 Turkey Oncology Therapeutic Drug Market Size, 2018-2029
6.8.4 Israel Oncology Therapeutic Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Oncology Therapeutic Drug Market Size, 2018-2029
6.8.6 UAE Oncology Therapeutic Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Oncology Therapeutic Drug Major Product Offerings
7.1.4 AbbVie Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncology Therapeutic Drug Major Product Offerings
7.2.4 Amgen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Astellas Pharma
7.3.1 Astellas Pharma Company Summary
7.3.2 Astellas Pharma Business Overview
7.3.3 Astellas Pharma Oncology Therapeutic Drug Major Product Offerings
7.3.4 Astellas Pharma Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Oncology Therapeutic Drug Major Product Offerings
7.4.4 AstraZeneca Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Oncology Therapeutic Drug Major Product Offerings
7.5.4 Bayer Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Biogen
7.6.1 Biogen Company Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Oncology Therapeutic Drug Major Product Offerings
7.6.4 Biogen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.6.5 Biogen Key News & Latest Developments
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Company Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Major Product Offerings
7.7.4 Bristol Myers Squibb Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.7.5 Bristol Myers Squibb Key News & Latest Developments
7.8 Celgene
7.8.1 Celgene Company Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene Oncology Therapeutic Drug Major Product Offerings
7.8.4 Celgene Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.8.5 Celgene Key News & Latest Developments
7.9 Eisai
7.9.1 Eisai Company Summary
7.9.2 Eisai Business Overview
7.9.3 Eisai Oncology Therapeutic Drug Major Product Offerings
7.9.4 Eisai Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.9.5 Eisai Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Oncology Therapeutic Drug Major Product Offerings
7.10.4 Eli Lilly and Company Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly and Company Key News & Latest Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Summary
7.11.2 Gilead Sciences Oncology Therapeutic Drug Business Overview
7.11.3 Gilead Sciences Oncology Therapeutic Drug Major Product Offerings
7.11.4 Gilead Sciences Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.11.5 Gilead Sciences Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Oncology Therapeutic Drug Business Overview
7.12.3 Ipsen Oncology Therapeutic Drug Major Product Offerings
7.12.4 Ipsen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.12.5 Ipsen Key News & Latest Developments
7.13 Johnson and Johnson
7.13.1 Johnson and Johnson Company Summary
7.13.2 Johnson and Johnson Oncology Therapeutic Drug Business Overview
7.13.3 Johnson and Johnson Oncology Therapeutic Drug Major Product Offerings
7.13.4 Johnson and Johnson Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.13.5 Johnson and Johnson Key News & Latest Developments
7.14 Merck
7.14.1 Merck Company Summary
7.14.2 Merck Business Overview
7.14.3 Merck Oncology Therapeutic Drug Major Product Offerings
7.14.4 Merck Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.14.5 Merck Key News & Latest Developments
7.15 Novartis
7.15.1 Novartis Company Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Oncology Therapeutic Drug Major Product Offerings
7.15.4 Novartis Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.15.5 Novartis Key News & Latest Developments
7.16 Otsuka Pharmaceutical
7.16.1 Otsuka Pharmaceutical Company Summary
7.16.2 Otsuka Pharmaceutical Business Overview
7.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
7.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.16.5 Otsuka Pharmaceutical Key News & Latest Developments
7.17 Pfizer
7.17.1 Pfizer Company Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Oncology Therapeutic Drug Major Product Offerings
7.17.4 Pfizer Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.17.5 Pfizer Key News & Latest Developments
7.18 F. Hoffmann-La Roche
7.18.1 F. Hoffmann-La Roche Company Summary
7.18.2 F. Hoffmann-La Roche Business Overview
7.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Major Product Offerings
7.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.18.5 F. Hoffmann-La Roche Key News & Latest Developments
7.19 Sanofi
7.19.1 Sanofi Company Summary
7.19.2 Sanofi Business Overview
7.19.3 Sanofi Oncology Therapeutic Drug Major Product Offerings
7.19.4 Sanofi Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.19.5 Sanofi Key News & Latest Developments
7.20 Takeda Pharmaceutical
7.20.1 Takeda Pharmaceutical Company Summary
7.20.2 Takeda Pharmaceutical Business Overview
7.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
7.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Pharmaceutical Key News & Latest Developments
7.21 Teva Pharmaceutical Industries
7.21.1 Teva Pharmaceutical Industries Company Summary
7.21.2 Teva Pharmaceutical Industries Business Overview
7.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Major Product Offerings
7.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.21.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Oncology Therapeutic Drug Production Capacity, Analysis
8.1 Global Oncology Therapeutic Drug Production Capacity, 2018-2029
8.2 Oncology Therapeutic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology Therapeutic Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology Therapeutic Drug Supply Chain Analysis
10.1 Oncology Therapeutic Drug Industry Value Chain
10.2 Oncology Therapeutic Drug Upstream Market
10.3 Oncology Therapeutic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology Therapeutic Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • がん用個別化医療のグローバル市場展望 2023年-2029年：免疫療法、標的療法、化学療法、ホルモン療法、その他
  • がん治療薬のグローバル市場2023-2027：標的療法、免疫療法、ホルモン療法、化学療法
  • 抗がん剤の世界市場2022：化学療法、標的療法、免疫療法、ホルモン療法（生物療法）、その他
  • 乳がん治療薬のグローバル市場（2023-2032）：化学療法、ホルモン療法、標的療法、免疫療法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5829 )"腫瘍治療薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、ホルモン療法、その他" (英文：Oncology Therapeutic Drug Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。